Bank Of Montreal Fulcrum Therapeutics, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $193,046 - $300,545	32,282 New	32,282 $200,000
Q4 2023 Feb 08, 2024	BUY	$3.18 - $6.86 $45,156 - $97,412	14,200 New	14,200 $95,000
Q4 2021 Feb 11, 2022	SELL	$14.0 - $28.44 $161,014 - $327,088	-11,501 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.28 - $30.97 $91,728 - $390,222	-12,600 Reduced 52.28%	11,501 $325,000
Q2 2021 Aug 12, 2021	BUY	$8.09 - $12.0 $194,977 - $289,212	24,101 New	24,101 $241,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.